When participants were categorized into quartiles based on MHR levels (Q1: < 0.293; Q2: 0.293–0.404; Q3: 0.404–0.550; Q4: ≥ 0.550), a clear trend of increasing MHR was observed across quartiles in the COPD group, while levels remained relatively stable in the non-COPD group.
← all excerpts
Association Between Monocyte-to-High Density Lipoprotein-Cholesterol Ratio and COPD Among US Adults: Findings from NHANES 1999-2018.
1
—
—